Raw material change implemented without assessment during deviation investigation – risk-based change impact assessment


Published on 25/04/2026

Managing Raw Material Changes Without Prior Assessment During Deviations: An Effective Playbook

The pharmaceutical industry faces a multitude of challenges regarding raw material management, particularly when material changes occur without proper assessment during deviation investigations. Such instances can lead to significant quality risks, potential regulatory implications, and devastating impacts on product safety. This article aims to provide a practical playbook for pharma professionals across various roles to effectively manage situations where raw material changes are implemented without necessary assessments.

By following the guidelines laid out in this playbook, professionals in Production, Quality Control (QC), Quality Assurance (QA), and Engineering can enhance their ability to respond to such critical situations efficiently. You will gain insights into signal identification, risk assessment, investigation workflows, and effective documentation practices to ensure compliance with FDA, EMA, and MHRA standards.

Symptoms/Signals on the Floor or in the Lab

Recognizing the early symptoms of unassessed raw material changes is crucial. Symptoms may manifest at various stages of the production or laboratory processes. Key

signs include:

  • Increased Deviations: A rise in product quality deviations or out-of-specification results can be an early warning sign of raw material issues.
  • Out-of-Trend Results: QC data showing unexpected trends or patterns can indicate a change in raw material characteristics.
  • Product Complaints: An increase in complaints pertaining to efficacy or safety may correlate with raw material sourcing changes.
  • Unexpected Equipment Performance: Changes in machine parameters may suggest that raw materials are not performing as intended.

Observation of these signals provides the important first step in identifying the underlying issues that require immediate attention.

Likely Causes (by category: Materials, Method, Machine, Man, Measurement, Environment)

Understanding the likely causes of deviations related to raw material changes can significantly aid in investigation and management. The following categories outline typical causes:

Category Likely Causes
Materials Unapproved or alternate raw materials used without proper assessment.
Method Changes in manufacturing processes that inadvertently affect product quality.
Machine Equipment malfunction or lack of maintenance contributions to variances.
Man Insufficient training or adherence to SOPs can lead to mishandling raw materials.
Measurement Improper calibration or malfunctioning measurement tools impacting quality metrics.
Environment Unexpected fluctuations in temperature or humidity affecting material integrity.
Pharma Tip:  Specification change not communicated during routine operations – regulatory expectations for material changes

Immediate Containment Actions (first 60 minutes)

Upon noticing signals of a potential issue stemming from a raw material change, it is critical to initiate immediate containment actions:

  1. Quarantine Affected Materials: Immediately isolate materials that are suspected of causing the issue to prevent further use.
  2. Stop Production: halt all relevant production processes to light a fire under response measures.
  3. Notify Relevant Teams: Alert QC, QA, Production, and Engineering teams to bring collective analytical resources into play.
  4. Review Documentation: Quickly gather all relevant documentation for affected batches, including source information for materials and batch records.
  5. Conduct Visual Inspections: Perform inspections of both the materials and production environment to identify any visible abnormalities.

Taking these steps within the first hour is crucial for managing risk and preventing a larger deviation incident.

Investigation Workflow (data to collect + how to interpret)

A structured investigation workflow is vital for documenting the circumstances and understanding the impact of unassessed changes. Focus on collecting the following data:

  • Batch Records: Detailed review of batch records associated with the deviation can provide insights into when and how the issue arose.
  • Material Certificates of Analysis (CoA): Evaluate CoAs to identify any discrepancies in raw material quality.
  • Process Parameters: Collect data on specific parameters during batch processing to find correlations with deviations.
  • Personnel Interviews: Conduct interviews with relevant personnel to gather qualitative data regarding the processing situation and any knowledge of material changes.

Once data is collected, categorize findings to trace back to specific materials, methods, and decisions. Understanding the timeline of events is critical in determining if the symptoms are indeed linked to the raw material change.

Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which

Utilizing formal root cause analysis (RCA) tools can illuminate underpinning reasons for material change deviations:

  • 5-Why Analysis: Use when you need to drill down efficiently from symptoms to root causes through successive questioning. Excellent for identifying systemic issues.
  • Fishbone Diagram: Ideal for multidisciplinary team settings. This visual tool categorizes potential causes, making it easier to identify correlations and contributing factors.
  • Fault Tree Analysis: Appropriate for complex problems that require assessing multiple failure events. Useful where multiple causes may be present.

Choose the appropriate tool based on the complexity of the issue and the resources available.

Pharma Tip:  Supplier change not evaluated during regulatory inspection – risk-based change impact assessment

CAPA Strategy (correction, corrective action, preventive action)

Effective handling of CAPA in response to raw material deviation is paramount:

  • Correction: Implement immediate corrective actions to contain the deviation and address any product already in process.
  • Corrective Action: Develop actions to prevent recurrence, such as heightened supplier evaluations or enhanced training for staff on change control processes.
  • Preventive Action: Institutionalize long-term measures through periodic reviews of raw material acceptance criteria and manufacturing protocols.

Well-documented CAPA decisions should reference data collected during the investigation for robust justification during inspections.

Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

A rigorous control strategy is essential post-incident:

  • Statistical Process Control (SPC): Implement trending for critical parameters of incoming materials to detect shifts in quality before they impact production.
  • Sampling Procedures: Enhance inspection and sampling protocols for raw materials to ensure consistent quality assurance.
  • Alarm Systems: Ensure that alert mechanisms are in place for out-of-bound quality metrics during production runs.
  • Verification Processes: Require periodic verification of raw material compliance from suppliers to ensure ongoing quality and reliability.

This comprehensive control strategy provides an added safety net, ensuring that similar incidents are detected and managed before they escalate.

Validation / Re-qualification / Change Control impact (when needed)

Following a raw material change implemented without assessment, a thorough validation approach is essential:

Related Reads

  • Validation Plan Review: Assess if existing validation plans can encompass the new raw material characteristics.
  • Re-qualification Efforts: Depending on the impact, consider re-qualification of processes affected by raw material changes.
  • Change Control Documentation: Document any changes in raw materials into the change control system, ensuring complete traceability.

Consistency in these activities supports quality control and compliance with regulatory requirements.

Inspection Readiness: what evidence to show (records, logs, batch docs, deviations)

To maintain inspection readiness following any deviations associated with unassessed raw material changes, the following documentation is essential:

  • Batch Records: Ensure thorough documentation of all pertinent batch records that reflect raw material use and outcomes.
  • Deviation Records: Document the deviation investigation outcomes, including timelines, individuals involved, and corrective measures taken.
  • Logs and Monitoring Reports: Maintain up-to-date logs for SPC and monitoring activities.
  • CAPA Documentation: All CAPA-related documentation must be robust, detailing the issues, root causes, and actions taken.
Pharma Tip:  Supplier change not evaluated during routine operations – regulatory expectations for material changes

This clear documentation provides a solid defense during inspections and can demonstrate compliance effectively.

FAQs

What should be the first step in handling a raw material change without assessment?

The first step should be to quarantine affected materials immediately to prevent further use and analyze potential impacts on existing products.

How can we improve our material traceability post-deviation?

Enhance material traceability by implementing robust tracking systems and ensuring comprehensive documentation of every material change within your change control processes.

What roles do team members play in managing raw material changes?

Production teams handle operations, QC checks raw material quality, QA ensures compliance with regulations, and Engineering evaluates process impacts.

What is the CAPA process after a raw material deviation?

The CAPA process includes immediate correction actions, development of corrective actions to prevent future issues, and preventive measures for long-term compliance.

Which root cause analysis tool is best for quick investigations?

The 5-Why Analysis tool is well-suited for quick investigations, as it enables rapid identification of root causes through a straightforward line of questioning.

How does SPC contribute to risk management?

Statistical Process Control (SPC) allows early detection of quality deviations through monitoring, ensuring that potential issues are flagged before they impact final products.

What documentation is critical during inspections?

Critical documentation includes batch records, deviation records, monitoring logs, and comprehensive CAPA documentation to showcase compliance efforts.

When is re-qualification necessary after a material change?

Re-qualification may be needed if the change in raw materials affects critical process parameters or product quality, requiring validation of the final output.

How can we safeguard against nitrosamine risks with raw materials?

Implement strict supplier assessments, enhanced testing for nitrosamines, and maintain updated change control documentation to mitigate associated risks.

What is the distance between minor deviations and significant issues with raw materials?

Minor deviations can escalate into significant issues if not thoroughly investigated; thus, maintaining attention to early signals is key in risk management.

Are change control processes the same across all regions?

No, while fundamental principles of change control may be consistent, regional regulations (FDA, EMA, MHRA) may have unique requirements that must be adhered to.

How can we cultivate a culture of quality related to raw materials?

Foster a culture of quality by emphasizing training, accountability, and engagement in quality processes across all teams involved in raw materials management.